Rifampicin-induced acute tubulointerstitial nephritis during pulmonary tuberculosis treatment : A case report

© 2023 The Authors. Respirology Case Reports published by John Wiley & Sons Australia, Ltd on behalf of The Asian Pacific Society of Respirology..

Drug-induced tubulointerstitial nephritis is an uncommon complication in patients on anti-tuberculosis therapy that can lead to permanent kidney damage. Rifampicin is the most offending drug. We report a case of a 41-years old man being treated for pulmonary tuberculosis and presenting with tubulointerstitial nephritis associated with rifampicin. We focus on diagnosis features and therapeutic challenges.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:11

Enthalten in:

Respirology case reports - 11(2023), 8 vom: 14. Aug., Seite e01190

Sprache:

Englisch

Beteiligte Personen:

Moussa, Chirine [VerfasserIn]
Esbaa, Samia [VerfasserIn]
Rouis, Houda [VerfasserIn]
Sellami, Nada [VerfasserIn]
Hajji, Meriam [VerfasserIn]
Houcine, Yoldez [VerfasserIn]
Khattab, Amel [VerfasserIn]
Khouaja, Ibtihel [VerfasserIn]
Zendah, Ines [VerfasserIn]
Maâlej, Sonia [VerfasserIn]

Links:

Volltext

Themen:

Acute kidney injury
Acute renal failure
Acute tubulointerstitial nephritis
Case Reports
Rifampicin
Tuberculosis

Anmerkungen:

Date Revised 21.07.2023

published: Electronic-eCollection

Citation Status PubMed-not-MEDLINE

doi:

10.1002/rcr2.1190

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM359700284